Cargando…

Extraintestinal Manifestations of Inflammatory Bowel Disease

Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with IBD significantly requiring specific treatment depending on the affected organ(s). They most frequently affect joint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vavricka, Stephan R., Schoepfer, Alain, Scharl, Michael, Lakatos, Peter L., Navarini, Alexander, Rogler, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Clinical Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511685/ https://www.ncbi.nlm.nih.gov/pubmed/26154136 http://dx.doi.org/10.1097/MIB.0000000000000392

Ejemplares similares

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients
por: Roth, René, et al.
Publicado: (2021)

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Roth, Nina, et al.
Publicado: (2019)

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort
por: Hiller, Aimee, et al.
Publicado: (2019)

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Biedermann, Luc, et al.
Publicado: (2019)

Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study
por: Kopylov, Uri, et al.
Publicado: (2023)

Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?
por: Rogler, Gerhard, et al.
Publicado: (2015)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
por: Vögelin, Marius, et al.
Publicado: (2016)

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
por: Grob, Lorenz, et al.
Publicado: (2020)

Microbial Sensing by the Intestinal Epithelium in the Pathogenesis of Inflammatory Bowel Disease
por: Scharl, Michael, et al.
Publicado: (2010)

Skin gangrene as an extraintestinal manifestation of inflammatory bowel disease
por: Komatsu, Yumi Cristina, et al.
Publicado: (2014)

Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fedor, Istvan, et al.
Publicado: (2021)

Extraintestinal Manifestations in Children Diagnosed with Inflammatory Bowel Disease
por: Kavcar, Zubeyr, et al.
Publicado: (2023)

Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study
por: Safroneeva, Ekaterina, et al.
Publicado: (2015)

Patients’ perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe? – a patient survey
por: Barthel, Christiane, et al.
Publicado: (2015)

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fleisher, Mark, et al.
Publicado: (2018)

Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients
por: Yang, Bo Ram, et al.
Publicado: (2018)

A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease
por: Annese, Vito
Publicado: (2019)

Extraintestinal manifestations of pediatric inflammatory bowel disease in Saudi Arabia
por: Al-Mendalawi, Mahmood D.
Publicado: (2018)

Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases
por: Kim, Jung Min, et al.
Publicado: (2020)

Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients
por: Adam, Heba, et al.
Publicado: (2020)

What are the risk factors for extraintestinal manifestations in inflammatory bowel diseases?
por: Yeo, Min-Kyung, et al.
Publicado: (2023)

Aseptic Splenic Abscess as Precursory Extraintestinal Manifestation of Inflammatory Bowel Disease
por: Brooks, Joel, et al.
Publicado: (2014)

Extraintestinal manifestation of inflammatory bowel disease and associated factors in pediatric patients
por: Rahmani, Parisa, et al.
Publicado: (2022)

Extraintestinal Manifestations of Inflammatory Bowel Disease Are Associated With Increased Biologic Cycling
por: Alizadeh, Madeline, et al.
Publicado: (2023)

Therapy Patterns and Surveillance Measures of Inflammatory Bowel Disease Patients beyond Disease-Related Hospitalization: A Claims-Based Cohort Study
por: Bähler, Caroline, et al.
Publicado: (2022)

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases
por: Fagagnini, Stefania, et al.
Publicado: (2017)

Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study
por: Schüle, Solvey, et al.
Publicado: (2017)

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn’s disease patients
por: Greuter, Thomas, et al.
Publicado: (2018)

Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
por: Martinho-Grueber, Maude, et al.
Publicado: (2022)

A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease
por: Cesa, Kevin, et al.
Publicado: (2022)

Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)

Extraintestinal manifestations of Crohn’s disease
por: Wójcik, Bartosz, et al.
Publicado: (2016)

Solid extraintestinal malignancies in patients with inflammatory bowel disease
por: Mala, Anastasia, et al.
Publicado: (2021)

Autoantibodies in the Extraintestinal Manifestations of Celiac Disease
por: Yu, Xuechen B., et al.
Publicado: (2018)

Protein Tyrosine Phosphatase Non-Receptor Type 22 Modulates NOD2-Induced Cytokine Release and Autophagy
por: Spalinger, Marianne R., et al.
Publicado: (2013)

Extraintestinal manifestations in irritable bowel syndrome: A systematic review
por: Ohlsson, Bodil
Publicado: (2022)

Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review
por: Massano, Alessandro, et al.
Publicado: (2023)

Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease
por: Barnhoorn, M C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9pqm02tumq0hjm4oojmlthm66t